Amadeo M. Parissenti
Greater Sudbury, ON P3E2C6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy.
Journal: Breast cancer research : BCR
Published: March 23, 2025
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.
Journal: JNCI cancer spectrum
Published: August 24, 2023
RNA disruption is a widespread phenomenon associated with stress-induced cell death in tumour cells.
RNA disruption is a widespread phenomenon associated with stress-induced cell death in tumour cells.
Journal: Scientific reports
Published: April 09, 2022
The RNA disruption assay is superior to conventional drug sensitivity assays in detecting cytotoxic drugs.
Journal: Scientific reports
Published: December 29, 2019
Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment.
Journal: Advances in experimental medicine and biology
Published: August 29, 2019
RNA disruption indicates CHOP therapy efficacy in canine lymphoma.
Journal: BMC veterinary research
Published: April 26, 2019
Bile Acids Increase Doxorubicin Sensitivity in ABCC1-expressing Tumour Cells.
Journal: Scientific reports
Published: June 29, 2017
Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
Journal: PloS one
Published: May 12, 2017
Last Updated: 09/26/2026